Evaluating markers in multiple sclerosis
Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis - MarkMS
Medical University of Graz · NCT04892134
This study is trying to find out which signs and markers can help doctors understand how multiple sclerosis progresses in patients at the Medical University of Graz.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years to 85 Years |
| Sex | All |
| Sponsor | Medical University of Graz (other) |
| Locations | 1 site (Graz, Styria) |
| Trial ID | NCT04892134 on ClinicalTrials.gov |
What this trial studies
This study investigates the clinical, morphological, and biochemical markers associated with multiple sclerosis (MS) to better understand the disease's progression. By analyzing various factors such as demographics, clinical assessments, neuropsychological tests, MRI results, and biochemical markers from blood and cerebrospinal fluid, the research aims to identify potential indicators that could aid in the clinical management of MS patients. The study is observational and focuses on gathering comprehensive data from patients receiving care at the Medical University of Graz.
Who should consider this trial
Good fit: Ideal candidates for this study are patients with suspected or confirmed multiple sclerosis who are receiving care at the Medical University of Graz.
Not a fit: Patients who cannot undergo MRI examinations or have contraindications for such procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with multiple sclerosis by identifying key biomarkers associated with disease progression.
How similar studies have performed: Other studies have shown promise in identifying biomarkers for multiple sclerosis, suggesting that this approach could yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with suspected or proven multiple sclerosis * The participants are patients who are in inpatient or outpatient care of the Department of Neurology at the Medical University of Graz, Austria Exclusion Criteria: * Excluded from the examinations are all patients for whom an MRI examination is impossible or problematic
Where this trial is running
Graz, Styria
- Medical University of Graz — Graz, Styria, Austria (RECRUITING)
Study contacts
- Principal investigator: Christian Enzinger, Prof — Medical University of Graz
- Study coordinator: Christian Enzinger, Prof.
- Email: chris.enzinger@medunigraz.at
- Phone: +43/316/ 385-82180
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Multiple Sclerosis, biomarker, progression, MRI, cognition